Tag: Propulsid

In 2000, after accumulating reports of serious, and sometimes fatal, cardiac arrhythmias, the manufacturer of Propulsid (cisapride) voluntarily withdrew the drug from the U.S. market. The medication, once a popular treatment for severe nocturnal heartburn, was discovered to carry a risk of a life-threatening heart rhythm disorder known as torsades de pointes.

In 2000, Janssen Pharmaceutica voluntarily stopped marketing the human version of cisapride (Propulsid) in the United States after hundreds of adverse event reports, including deaths, were linked to the drug's use. The key question, "Is cisapride still available?", now has a complex answer depending on the patient and species in question.

In July 2000, Propulsid (cisapride) was removed from the U.S. market due to reports of serious cardiac arrhythmias and death. For patients wondering, 'Is there a replacement for Propulsid?', the answer lies in modern, safer prokinetic agents.

Cisapride (Propulsid®) was voluntarily withdrawn from the U.S. market in 2000 due to numerous reports of fatal cardiac arrhythmias. Understanding how to take cisapride is therefore critical, but only applies to the very few patients who still qualify for its use through a highly restrictive compassionate-use program.

In July 2000, following multiple reports of severe cardiac arrhythmias and fatalities, the GI motility drug Propulsid (cisapride) was voluntarily withdrawn from the U.S. market by its manufacturer. This action has led many to question, 'Can you still get Propulsid?', and the answer for most people is a definitive no.

In 2000, after accumulating reports of serious cardiac events and fatalities, the popular heartburn drug Propulsid (cisapride) was voluntarily withdrawn from the U.S. market. This article explores what Propulsid was, its intended use, the reasons for its removal, and the important lessons learned about drug safety and monitoring.